Navigation Links
Brandeis scientist invents anti-cholesterol process
Date:6/18/2013

Senior Brandeis research scientist Daniel Perlman has discovered a way to make phytosterol molecules from plants dispersible in beverages and foods that are consumed by humans, potentially opening the way to dramatic reductions in human cholesterol levels.

A U.S. patent (#8,460,738) on the new process and composition was issued on June 11.

Phytosterols in plants and cholesterol molecules in animals are highly similar and when both are dispersed together they are attracted to one another. When they mix in the gut of an animal, the cholesterol molecules are competitively inhibited from passing into the blood stream and instead are excreted.

The ability of phytosterols to reduce cholesterol levels in animals has been recognized since the 1950s, but practical application of this knowledge was difficult because phytosterols are not naturally water-soluble, and they are only poorly soluble in fatty substances.

Perlman and K.C. Hayes, professor emeritus of biology and former director of the Foster Biomedical Research Laboratories, invented and patented a way to increase the bioavailability of phytosterols in fats more than 10 years ago. Their separate discoveries relating to fat metabolism and oxidative stability led to development of the Smart Balance blend of oils and a number of other food products.

However, improving dispersal of phytosterols in water has remained problematic, and was an obstacle to their general use in foods and beverages. Phytosterols placed in water-based substances will not disperse, and this has thwarted their cholesterol-reducing potential.

Now, Perlman has found a way to change the behavior of phytosterols in liquids by forming a new complex in which glycerin molecules attach to phytosterol molecules. Phytosterols and glycerin are heated together to a temperature at which the water molecule that usually attaches to each phytosterol molecule boils off and is replaced by a glycerin molecule. Because glycerin molecules have multiple places at which water molecules can be attached and because glycerin also inhibits crystal growth that complicates dispersal, the phytosterol-glycerin complex together with an emulsifier becomes dispersible in water-based foods.

"I had been playing with ideas on how to enhance the dispersibility of this molecule for a number of years," said Perlman, who has more than 100 patents and pending patents on inventions he has made in his years at Brandeis. This was critically important, he explained, because "if you really want to have widespread public health benefits, you want to be able to put [phytosterols] in foods and beverages."

Hayes said he has tested Perlman's new compound on gerbils in his laboratory and obtained results from the water-dispersed phytosterols that are excellent in terms of their cholesterol-reducing action.

Physics Professor Seth Fraden, who is director of the Brandeis Materials Research Science and Engineering Center, said "the actual science of how it all works" when the attachment of glycerin changes phytosterol behavior "is not understood."

Perlman, he said, "had a chemical intuition for doing this. He is a good chemist; he has a feeling for molecules and what they'll do when you mix them. In addition to this intuition, he is very open-minded and will go in the lab and try things that other people don't do because their professors have told them it won't work.

"That's why he's a good inventor," Fraden said.


'/>"/>

Contact: Charles A. Radin
radin@brandeis.edu
781-736-4210
Brandeis University
Source:Eurekalert

Related medicine news :

1. Scientists at UMass Medical School identify neurons that control feeding behavior in Drosophila
2. Scientists ID Gene Behind Early Onset Puberty
3. NIH scientists discover how HIV kills immune cells
4. Scientists find potential new clues for identifying breast cancer risk
5. PolyU Scientists Help Identify Genes Causing Myopia
6. Scientists Gauge Radiation Dose From Trip to Mars
7. Scientists Spot Genes Tied to Success at School, College
8. German and Israeli scientists gain new insights into protein disposal
9. Scientists Cant Replicate Surprising Finding on Alzheimers Treatment
10. Scientists discover how rapamycin slows cell growth
11. Scientists Map the Fungi on Your Feet
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2016)... ... May 26, 2016 , ... An April Gallup survey found rising health ... employees of Sun Health Senior Living (SHSL) may not share those same ... and prescription copays for the year, while holding the line on increasing their contributions, ...
(Date:5/26/2016)... ... May 26, 2016 , ... Leadership of ... today announced the organization has earned its ISO 13485 certification, indicating the company’s ... with all rules and policies associated with ISO quality standard 13485. , ...
(Date:5/26/2016)... ... ... North Cypress Medical Center hosted its 9th Annual Spring Classic Golf ... of community partners, the event organizers raised $45,000 for the Lone Survivor Foundation ... their families through health, wellness, and therapeutic support. , A special military three-plane ...
(Date:5/26/2016)... ... May 26, 2016 , ... The MIAMI Institute for Age ... speaker Dr. Adonis Maiquez MD, ABAARM. Dr. Adonis , Wellness Physician of the ... a member of the Institute for Functional Medicine. , He also heads up FITTLab, ...
(Date:5/26/2016)... CA (PRWEB) , ... May 26, 2016 , ... ... (also knowns as a bunionette) treatment was more than humbled by customer demand over ... one of their SKU's mid sale. Now that Bunion Bootie has completely replenished its ...
Breaking Medicine News(10 mins):
(Date:5/26/2016)... , May 26, 2016 ... Associated With Both Cost Savings and Overall ... plc (LSE: BTG), an international specialist healthcare company, ... at the 21st Annual Meeting of ISPOR (International ... treatment of hepatocellular carcinoma (HCC) using yttrium-90 glass ...
(Date:5/25/2016)... , May 25,2016 ... the near-infrared Cellvizio platform for urological and surgical ... OTCQX: MKEAY) inventor of Cellvizio®, the multidisciplinary confocal ... regulatory milestone in the US with the 12 ... and Drug Administration (FDA). This new FDA clearance ...
(Date:5/25/2016)... and GERMANTOWN, Maryland , May 25, ... QGEN ; Frankfurt Prime Standard: QIA) today announced that the ... Therawis Diagnostics GmbH to develop and commercialize predictive assays in ... PITX2 as a marker to predict effectiveness of anthracycline treatment ... "We are pleased to partner with Therawis, which developed ...
Breaking Medicine Technology: